Skip to main content
Top
Published in: Obesity Surgery 11/2014

01-11-2014 | Original Contributions

Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible?

Authors: Robson K. Ishida, Joel Faintuch, Adriana Safatle Ribeiro, Ulysses Ribeiro Jr., Ivan Cecconello

Published in: Obesity Surgery | Issue 11/2014

Login to get access

Abstract

Background

Patients with postbariatric bacterial overgrowth were reinvestigated after a follow-up of 15 years. It was hypothesized that systemic associations analogous to those reported for whole gut microbiome would be revealed.

Methods

Patients (n = 37, 70.3 % females, 42.4 ± 9.9 years old, preoperative BMI 53.5 ± 10.6 kg/m2, current BMI 32.8 ± 10.8 kg/m2), all submitted to RYGB on account of morbid obesity, were followed during 176.8 ± 25.7 months. Blood tests included fasting blood glucose, HbA1c, liver and pancreatic enzymes, and lipid fractions. Bacterial overgrowth was diagnosed by quantitative culture of gastric fluid in both the excluded remnant and the gastric pouch, with the help of double-balloon enteroscopy. Absolute counts of aerobes and anaerobes in both gastric reservoirs were correlated with nutritional and biochemical measurements, aiming to identify clinically meaningful associations.

Results

Patients denied diarrhea, abdominal pain, weight loss, or other symptoms related to bacterial overgrowth. Biochemical profile including enzymes was also acceptable, indicating a stable condition. Positive correlation of bacterial count in either segment of the stomach was demonstrated for BMI and gamma-glutamyl transferase, whereas negative correlation occurred regarding fasting blood glucose.

Conclusions

An antidiabetic role along with deleterious consequences for weight loss and liver function are possible in such circumstances. Such phenotype is broadly consistent with reported effects for the whole gut microbiome. Prospective controlled studies including molecular analysis of gastrointestinal fluid, and simultaneous profiling of the entire microbiome, are necessary to shed more light on these findings.
Literature
1.
go back to reference Schmalstieg Jr FC, Goldman AS. Ilya Ilich Metchnikoff (1845-1915) and Paul Ehrlich (1854-1915): the centennial of the 1908 Nobel Prize in Physiology or Medicine. J Med Biogr. 2008;16:96–103.PubMedCrossRef Schmalstieg Jr FC, Goldman AS. Ilya Ilich Metchnikoff (1845-1915) and Paul Ehrlich (1854-1915): the centennial of the 1908 Nobel Prize in Physiology or Medicine. J Med Biogr. 2008;16:96–103.PubMedCrossRef
2.
go back to reference Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9:590–8.PubMedCrossRef Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9:590–8.PubMedCrossRef
4.
go back to reference Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17:752–8.PubMedCrossRef Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17:752–8.PubMedCrossRef
5.
go back to reference Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol. 2011;9:461–9.PubMedCrossRef Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol. 2011;9:461–9.PubMedCrossRef
6.
go back to reference Yu D, Cheeseman F, Vanner FS. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60:334–40.PubMedCrossRef Yu D, Cheeseman F, Vanner FS. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60:334–40.PubMedCrossRef
7.
go back to reference Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178–41.CrossRef Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178–41.CrossRef
8.
go back to reference Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–6. e7.PubMedCrossRef Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–6. e7.PubMedCrossRef
9.
go back to reference Ockeloen LE, Deckers-Kocken JM. Short- and long-term effects of a lactose-restricted diet and probiotics in children with chronic abdominal pain: a retrospective study. Complement Ther Clin Pract. 2012;18:81–4.PubMedCrossRef Ockeloen LE, Deckers-Kocken JM. Short- and long-term effects of a lactose-restricted diet and probiotics in children with chronic abdominal pain: a retrospective study. Complement Ther Clin Pract. 2012;18:81–4.PubMedCrossRef
10.
go back to reference Sabaté JM, Jouët P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18:371–7.PubMedCrossRef Sabaté JM, Jouët P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18:371–7.PubMedCrossRef
11.
go back to reference Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877–87.PubMedCrossRef Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877–87.PubMedCrossRef
12.
go back to reference Shanab AA, Scully P, Crosbie O, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with Toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011;56:1524–34.PubMedCrossRef Shanab AA, Scully P, Crosbie O, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with Toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011;56:1524–34.PubMedCrossRef
13.
go back to reference Madrid AM, Poniachik J, Quera R, et al. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci. 2011;56:155–60.PubMedCrossRef Madrid AM, Poniachik J, Quera R, et al. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci. 2011;56:155–60.PubMedCrossRef
14.
go back to reference Machado JD, Campos CS, Lopes Da Silva C, et al. Intestinal bacterial overgrowth after Roux-em-Y gastric bypass. Obes Surg. 2007;17:1529–33.CrossRef Machado JD, Campos CS, Lopes Da Silva C, et al. Intestinal bacterial overgrowth after Roux-em-Y gastric bypass. Obes Surg. 2007;17:1529–33.CrossRef
15.
go back to reference Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483–90.PubMedCrossRef Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483–90.PubMedCrossRef
16.
go back to reference Ratuapli SK, Ellington TG, O'Neill MT, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012;107:730–5.PubMedCrossRef Ratuapli SK, Ellington TG, O'Neill MT, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012;107:730–5.PubMedCrossRef
17.
go back to reference George NS, Sankineni A. Parkman HP. Dig Dis Sci: Small intestinal bacterial overgrowth in gastroparesis; 2012. George NS, Sankineni A. Parkman HP. Dig Dis Sci: Small intestinal bacterial overgrowth in gastroparesis; 2012.
18.
go back to reference Klaus A, Weiss H, Kreczy A, et al. A new biliodigestive anastomosis technique to prevent reflux and stasis. Am J Surg. 2001;182:52–7.PubMedCrossRef Klaus A, Weiss H, Kreczy A, et al. A new biliodigestive anastomosis technique to prevent reflux and stasis. Am J Surg. 2001;182:52–7.PubMedCrossRef
19.
go back to reference Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28:293–8.PubMedCrossRef Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28:293–8.PubMedCrossRef
20.
go back to reference Corrodi P. Jejunoileal bypass: change in the flora of the small intestine and its clinical impact. Rev Infec Dis. 1984;6 Suppl 1:S80–4.CrossRef Corrodi P. Jejunoileal bypass: change in the flora of the small intestine and its clinical impact. Rev Infec Dis. 1984;6 Suppl 1:S80–4.CrossRef
21.
go back to reference Leung FW, Drenick EJ, Stanley TM. Intestinal bypass complications involving the excluded bowel segment. Am J Gastroenterol. 1982;77:67–72.PubMed Leung FW, Drenick EJ, Stanley TM. Intestinal bypass complications involving the excluded bowel segment. Am J Gastroenterol. 1982;77:67–72.PubMed
22.
go back to reference Rana SV, Sharma S, Kaur J, et al. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion. 2012;85:243–7.PubMedCrossRef Rana SV, Sharma S, Kaur J, et al. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion. 2012;85:243–7.PubMedCrossRef
23.
go back to reference Asemi Z, Zare Z, Shakeri H, et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013;63:1–9.PubMedCrossRef Asemi Z, Zare Z, Shakeri H, et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013;63:1–9.PubMedCrossRef
24.
go back to reference Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13:1198–204.PubMedCrossRef Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13:1198–204.PubMedCrossRef
25.
go back to reference Shin DW, Kwon HT, Kang JM, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol. 2012;46:840–5.PubMedCrossRef Shin DW, Kwon HT, Kang JM, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol. 2012;46:840–5.PubMedCrossRef
26.
go back to reference Steineman DC, Bueter M, Schiesser M, Amygdalos I, Clavien PA, Nocito A. Management of anastomotic ulcers after Roux-en-Y Gastric Bypass: results of an International Survey. Obes Surg 2013 Dec 18 Steineman DC, Bueter M, Schiesser M, Amygdalos I, Clavien PA, Nocito A. Management of anastomotic ulcers after Roux-en-Y Gastric Bypass: results of an International Survey. Obes Surg 2013 Dec 18
27.
go back to reference Petrof EO, Claud EC, Gloor GB, et al. Microbial ecosystems therapeutics: a new paradigm in medicine ? Benef Microbes. 2013;4:53–65.PubMedCrossRef Petrof EO, Claud EC, Gloor GB, et al. Microbial ecosystems therapeutics: a new paradigm in medicine ? Benef Microbes. 2013;4:53–65.PubMedCrossRef
28.
go back to reference Allen-Vercoe E, Reid G, Viner N, et al. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol. 2012;26:457–62.PubMedPubMedCentral Allen-Vercoe E, Reid G, Viner N, et al. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol. 2012;26:457–62.PubMedPubMedCentral
29.
go back to reference Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome. 2013;1:3–9.PubMedCrossRefPubMedCentral Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome. 2013;1:3–9.PubMedCrossRefPubMedCentral
Metadata
Title
Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible?
Authors
Robson K. Ishida
Joel Faintuch
Adriana Safatle Ribeiro
Ulysses Ribeiro Jr.
Ivan Cecconello
Publication date
01-11-2014
Publisher
Springer US
Published in
Obesity Surgery / Issue 11/2014
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1277-z

Other articles of this Issue 11/2014

Obesity Surgery 11/2014 Go to the issue